Physician's Weekly

JUNE 18, 2025

food supply by the end of 2026. Department of Health and Human Services and the Food and Drug Administration (FDA) announced a plan to work with food companies to remove six synthetic dyes from the U.S. The effort is part of U.S. Health Secretary Robert F. Kennedy Jr. ’s s “Make America Healthy Again” — or MAHA — initiative.

Government 96

Government IT 96

The Physicians Foundation

MARCH 26, 2025

Research Resources Grants About Leadership Annual Reports Fellowship Program Leadership Award Program Brandeis Leadership Institute Newsroom Surveys Stories Connect ; Connect FILTER BY Year 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 Search Results News Is Healthcare Consolidation Fueling the Physician Burnout Crisis?

Healthcare 52

Healthcare 52

The Physicians Foundation

MARCH 26, 2025

Research Resources Grants About Leadership Annual Reports Fellowship Program Leadership Award Program Brandeis Leadership Institute Newsroom Surveys Stories Connect ; Connect FILTER BY Year 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 Search Results News How drivers of health screenings led to immediate patient impact and practice sustainability (..)

Screening 52

Screening Patients Healthcare 52

ABIM

MARCH 27, 2025

The Program begins in September 2025 and concludes at the ABMS Conference in September 2026. ABMS Visiting Scholars are selected based on the quality of their proposed research project.

Board-Certified 52

Board-Certified Medical Specialty Internal Medicine Education 52

Medical Xpress

JANUARY 30, 2023

government could save billions every year once Medicare begins negotiating drug prices in 2026, new research suggests.

Government 75

Government Medical 75

FDA Law Blog

MARCH 19, 2024

Hyman, Phelps & McNamara, P.C. (HP&M), HP&M), the largest dedicated food and drug law firm in the U.S., is pleased to announce that Director Allyson Mullen has been appointed to the Board of Directors of the Association of Medical Diagnostic Manufacturers (AMDM). This prestigious appointment recognizes Ms.

Appointment 59

Appointment Manufacturing Medical Education 59

Pamela Wible MD

MAY 21, 2025

2026 Physician Vision Quest Retreat Dec 3–7, 2025 ~ 1:1 or small group retreat Craving clarity before the new year? Tax-deductible. CME included. By invitation only. Enjoy a year-end physician wellness retreat—your opportunity to step away from the noise and tune in to divine guidance. Tax-deductible. 30 hours category 2 CME.

Private Practice 180

Private Practice Consulting Medical Student Engineering 180

FDA Law Blog

MARCH 5, 2024

AstraZeneca also claimed that CMS’s revised guidance on the Negotiation Program for Price Applicability Year 2026 (“Guidance”) interpreted the IRA in two very faulty ways, which violated the Administrative Procedure Act (APA) and harmed and will continue to harm the company. The court found numerous flaws with this argument.

Government 64

Government IT Manufacturing Illness 64

Minnesota Academy of Family Physicians

MARCH 13, 2025

Key Changes: It implements a base year payment rate structure effective January 1, 2026, which will set specific payment rates for various levels of care, including outpatient and residential treatment services, and mandates annual adjustments based on the Medicare Economic Index, beginning January 1, 2027.

Patient-Centered 52

Patient-Centered Telehealth Management Finance 52

PEMBlog

OCTOBER 31, 2024

N Engl J Med 2018; 379:2015-2026. N Engl J Med. 2018 Nov 22;379(21):2002-2014. doi: 10.1056/NEJMoa1802598. PMID: 30462938; PMCID: PMC6358014. Freedman et al. Multicenter Trial of a Combination Probiotic for Children with Gastroenteritis. DOI: 10.1056/NEJMoa1802597. Parker et al. Pediatrics, 2013. Szajewska et al.

Hospital 105

Hospital Illness Patients Provider 105

Plum Health

AUGUST 20, 2023

WSU SOM’s incoming class of 2026 had 300 Students, with 192 in-state and 108 out-of-state students. These medical students will be immersed in the Detroit community over the next 4 years, and upon graduation, many of them will continue to serve the Detroit and Metro Detroit community.

Medical Student 52

Medical Student Community Specialization Medical 52

ABIM

JUNE 20, 2025

ABIM is pleased to announce openings on the Board of Directors , ABIM Council and several Specialty Boards for initial three-year terms beginning July 1, 2026. Applications are due Sunday, July 20, 2025. ABIM Governance provides a meaningful and rewarding opportunity to join outstanding colleagues in service to the profession and to patients.

Government 40

Government Board-Certified Internal Medicine Community 40

FDA Law Blog

NOVEMBER 11, 2024

That means almost certainly no sooner than the second half of 2026. Notably, the proposed order provides that the order, if finalized, will become effective one year after the final rule is published.

Provider 111

Provider IT Management 111

FDA Law Blog

SEPTEMBER 16, 2024

Regarding CDER’s ETP, the current ETP guidance document, originally published in 2017, will be updated by the end of 2026, and will include details on communicating the type of products and stages of development for which a requestor can approach the ETP.

Manufacturing 59

Manufacturing IT Supply Chain Provider 59

FDA Law Blog

JUNE 26, 2023

September 1, 2023 will be the selection date for the 10 drugs that will be subject to “maximum fair price” ceilings under Medicare Part D starting in 2026. Chamber of Commerce makes all the arguments that the other plaintiffs have made, and also alleges that Congress has no power to levy the excise tax because it “compels” commerce.

Manufacturing 59

Manufacturing IT Government 59

FDA Law Blog

FEBRUARY 2, 2025

California pharmacists are still able to provide the oral therapeutics without requiring you to visit your primary care physician through January 1, 2026. The most common drug Californians may be looking for this winter is Paxlovid.

Primary Care Physician 59

Primary Care Physician Primary Care Diagnosis Provider 59

FDA Law Blog

DECEMBER 23, 2024

This means that, at the current moment, FDA cannot award any priority review vouchers for rare pediatric disease product applications unless it is for a drug that was designated as a drug for a rare pediatric disease not later than December 20, 2024, and such application is approved not later than September 30, 2026.

IT 59

IT Government 59

ABIM

JUNE 12, 2025

The Specialty Board discussed strategies for recruiting Item-Writers and broader engagement with the geriatric medicine community and will work with ABIM staff to explore possibilities for in-person events or engagements at upcoming society national meetings in 2026 and 2027.

Board-Certified 52

Board-Certified Internal Medicine Government Community 52

FDA Law Blog

OCTOBER 13, 2024

No rare pediatric disease vouchers could be awarded even to designated applications after September 30, 2026. After this date, without action by Congress, FDA’s authority to grant rare pediatric disease designations would expire, and no vouchers could be granted unless previously granted such a designation.

Government 64

Government IT Education Individual 64

FDA Law Blog

FEBRUARY 21, 2024

One of the major changes is the extension of the transition period from one to two years, with FDA now planning to enforce the QMSR requirements upon the effective date of the final rule on February 2, 2026.

Manufacturing 59

Manufacturing Management Medical IT 59

FDA Law Blog

OCTOBER 12, 2023

Priority is given to Suitability Petitions that could mitigate or resolve a drug shortage; address a public health emergency declared by HHS; mitigate waste by way of new strengths for parenteral products; or subject to special review under the President’s Emergency Plan for Aids Relief.

Specialization 59

Specialization IT 59

FDA Law Blog

FEBRUARY 11, 2025

However, as we suggested in a recent blog post , the statute did not actually provide any limitations on FDAs authority to grant rare pediatric disease designations , only its authority to grant vouchers.

IT 59

IT Families Family Provider 59

FDA Law Blog

SEPTEMBER 22, 2024

Complaints FDA discussed how LDT developers should handle the transition from the current Quality System Regulation (QSR)(21 CFR Part 820) to the recently promulgated Quality Management System Regulation (QMSR) that is scheduled to take effect on February 2, 2026.

Manufacturing 64

Manufacturing Electronics Provider Management 64

FDA Law Blog

SEPTEMBER 20, 2021

Notable Dates and Timelines – Program opens, beginning of FY 2023; Expediting reviews fully implemented, by FY 2024; Webpage with detailed criteria for acceptance and participation, October 1, 2022; Interim assessment, end of FY 2025; Public workshop, end of Q2 FY 2026. Notable Dates and Timelines – New MAPP published, by Dec.

Patient-Centered 52

Patient-Centered Manufacturing Clinic Provider 52

FDA Law Blog

OCTOBER 4, 2023

Note that Astellas withdrew its lawsuit after none of its drugs were selected for price reduction in 2026—potentially because that fact cut against its argument for standing. Harm The Court reviewed the parties’ arguments on “irreparable harm to Plaintiffs.”

Provider 59

Provider Manufacturing IT Government 59

FDA Law Blog

APRIL 14, 2022

The draft MDUFA V commitment letter starts with a 70% goal in FY 2023, but if the de novo decision goal is met in FY 2023 and the fee revenue amount provided for FY 2026 and 2027 is adequate to support performance improvements, FDA plans to increase the goal to 80% in FY 2026.

Provider 40

Provider Clinic Medical IT 40

FDA Law Blog

NOVEMBER 16, 2021

In 2025, the Secretary would select no more than 10, 15 in 2026, 15 in 2027, and 20 in 2028 and subsequent years. Select a limited number for negotiation (“selected drugs”) and enter into agreements with their manufacturers to negotiate a “maximum fair price.”

Manufacturing 52

Manufacturing Government IT Complication 52

FDA Law Blog

FEBRUARY 13, 2025

Post-market surveillance plans and procedures (PMS) are a requirement under ISO 13485 which will be adopted into FDAs Quality Management System Regulation in 2026.

Manufacturing 71

Manufacturing Management Specialization Provider 71

Physician's Weekly

JUNE 25, 2025

Dangerous changes loomed: To compensate for tax cuts for the wealthy, Trump’s “big, beautiful” bill and budget proposal for fiscal year 2026 threaten to curtail Medicaid, which provides health coverage for people with low incomes and disabilities. About 40% of adults with HIV rely on it for their lifesaving treatments.

52

52

FDA Law Blog

DECEMBER 3, 2023

On November 17th, CMS issued its final guidance on the Discount Program in which it responded to public comments and provided updated guidance for the Discount Program for 2025 and 2026. The Discount Program is similar to the CGDP with respect to several requirements and operational processes, and CMS will implement it in a similar manner.

Manufacturing 105

Manufacturing Provider IT Electronics 105

Physician's Weekly

JUNE 17, 2025

19, 2026 (production code: 241019) and to thoroughly disinfect items and surfaces that may have come in contact with the product. One person has been hospitalized; however, no deaths have been reported at this time. Salmonella can cause diarrhea, fever, vomiting, stomach cramps, and dehydration.

Illness 40

Illness Individual Hospital 40

Alabama Academy of Family Physicians

FEBRUARY 19, 2025

It then establishes a new Rural Physician Income Tax Credit program, effective January 1, 2026, that provides a $10,000 annual tax credit to qualifying rural physicians for up to four tax years.

Insurance 130

Insurance Management Hospital Vaccination 130

FDA Law Blog

JUNE 14, 2023

In FY 2026 – FY 2027, continue to support products enrolled in previous fiscal years and expand to enroll up to 100 additional products each fiscal year within existing OHTs or expand to additional OHTs, depending on lessons learned from FY 2023 – FY 2025 experience (i.e., up to 125 total products enrolled through FY 2025).

Manufacturing 45

Manufacturing Medical Patient-Centered Appointment 45

ABIM

JUNE 4, 2025

They also reviewed Approval Committee meetings with information about the rate of items approved and goals for the coming year, including preparation for the Blueprint Review that will occur in 2026.

Diabetes 52

Diabetes Board-Certified Telehealth Government 52

ABIM

JUNE 11, 2025

After similar explorations in gastroenterology , hematology and medical oncology , ABIM announced the development of several new focused LKAs planned for launch in those areas in 2026.

Board-Certified 52

Board-Certified Government Community Education 52

ABIM

JUNE 24, 2025

Of note, they reported that the committees and the task force are ahead of schedule for developing new items to feature on the focused versions of the Hematology LKA launching in 2026. Learn More Subscribe to the ABIM Blog to stay on top of the latest news.

40

40

FDA Law Blog

OCTOBER 20, 2022

FY 2026, device manufacturers should take advantage of reduced fees if they qualify as a small business. The same is true when the range of the percent change in the medical device user fees from FY2022 to FY2023 is compared to other FDA programs (e.g., prescription drug user fees , generic drug user fees , and biosimilar user fees ).

Medical 59

Medical Manufacturing Provider 59